Skip to main content
SpringerLink
Log in

Safety profile of six months lansoprozole treatment in children

  • Letter
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tolia V, Boyer K. Long term proton pump inhibitor use in children: A retrospective review of safety. Dig Dis Sci. 2008;53:385–93.

    Article  CAS  PubMed  Google Scholar 

  2. McColl KE. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol. 2009;104:5–9.

    Article  Google Scholar 

  3. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J. 2004;97:887–9.

    Article  PubMed  Google Scholar 

  4. Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol. 2000;30:29–33.

    Article  CAS  PubMed  Google Scholar 

  5. Insogna KL. The effect of proton pump-inhibiting drugs on mineral metabolism. Am J Gastroenterol. 2009;104:2–4.

    Article  Google Scholar 

  6. Schinke T, Schilling AF, Baranowsky A, et al. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med. 2009;15:674–81.

    Article  CAS  PubMed  Google Scholar 

  7. Kocsis I, Arató A, Bodánszky H, et al. Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children. Calcif Tissue Int. 2002;71:129–32.

    Article  CAS  PubMed  Google Scholar 

  8. Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947–53.

    Article  CAS  PubMed  Google Scholar 

  9. Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: A population-based case-control study. Arch Intern Med. 2007;167:950–5.

    Article  CAS  PubMed  Google Scholar 

  10. Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:817–20.

    Article  Google Scholar 

Download references

Conflict of Interests

None.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Gastroenterology and Hepatology, Eskisehir Osmangazi University, Faculty of Medicine, Eskisehir, Turkey

    Makbule Eren

  2. Department of Pediatrics, Eskisehir Osmangazi University, Faculty of Medicine, Eskisehir, Turkey

    Selda Hekim Yıldırım

  3. Department of Nuclear Medicine, Eskisehir Osmangazi University, Faculty of Medicine, Eskisehir, Turkey

    Ilknur Ak Sivrikoz

Authors
  1. Makbule Eren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Selda Hekim Yıldırım
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilknur Ak Sivrikoz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Makbule Eren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eren, M., Yıldırım, S.H. & Sivrikoz, I.A. Safety profile of six months lansoprozole treatment in children. Indian J Gastroenterol 29, 247–248 (2010). https://doi.org/10.1007/s12664-010-0077-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-010-0077-1

Keywords

Search

Navigation